Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells

Neurochemistry International

Volumn 58, Issue 2, 2011, Pages 153-160

  Lee, Ik Soo ^a   Lim, Juhee ^a   Gal, Jiyeong ^a   Kang, Jeen Chu ^a   Kim, Hyun Jung ^a   Kang, Bok Yun ^a   Choi, Hyun Jin ^a  

^a Chonnam National University   (South Korea)

Author keywords

Anti inflammation; BV2; Heme oxigenase 1; Microglia; Nrf2; Xanthohumol

Indexed keywords

DICOUMAROL; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTOPORPHYRIN ZINC; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; XANTHOHUMOL;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; GENETIC TRANSFECTION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; FLAVONOIDS; GLIOSIS; HEME OXYGENASE-1; INFLAMMATION; INFLAMMATION MEDIATORS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE PROTEINS; MICE; MICROGLIA; NF-E2-RELATED FACTOR 2; PROPIOPHENONES; PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; HUMULUS LUPULUS;

EID: 78651259607     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.11.008     Document Type: Article

References (54)

1. I. Adcock Transcription factors as activators of gene transcription: AP-1 and NF-kappa B Monaldi Arch. Chest Dis. 52 1997 178 186
2. V. Bocchini, R. Mazzolla, R. Barluzzi, E. Blasi, P. Sick, and H. Kettenmann An immortalized cell line expresses properties of activated microglial cells J. Neurosci. Res. 31 1992 616 621
3. Y. Cho, H. Kim, Y. Kim, K. Lee, H. Choi, I. Lee, and B. Kang Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages Int. Immunopharmacol. 8 2008 567 573
4. A. Cuadrado, and A. Rojo Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections Curr. Pharm. Des. 14 2008 429 442
5. B. Dietz, Y. Kang, G. Liu, A. Eggler, P. Yao, L. Chadwick, G. Pauli, N. Farnsworth, A. Mesecar, R. van Breemen, and J. Bolton Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase Chem. Res. Toxicol. 18 2005 1296 1305
6. W. Duan, R. Zhang, Y. Guo, Y. Jiang, Y. Huang, H. Jiang, and C. Li Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice In Vitro Cell. Dev. Biol. Anim. 45 2009 388 397
7. C. Fremond, D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. Quesniaux IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection J. Immunol. 179 2007 1178 1189
8. A. Hässig, W. Liang, H. Schwabl, and K. Stampfli Flavonoids and tannins: plant-based antioxidants with vitamin character Med. Hypotheses 52 1999 479 481
9. E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhäuser Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms J. Biol. Chem. 276 2001 32008 32015
10. T. Hsieh, X. Lu, Z. Wang, and J. Wu Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2 Med. Chem. 2 2006 275 285
11. S. Hunot, N. Dugas, B. Faucheux, A. Hartmann, M. Tardieu, P. Debré, Y. Agid, B. Dugas, and E. Hirsch FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells J. Neurosci. 19 1999 3440 3447
12. N. Innamorato, A. Rojo, A. García-Yagüe, M. Yamamoto, M. de Ceballos, and A. Cuadrado The transcription factor Nrf2 is a therapeutic target against brain inflammation J. Immunol. 181 2008 680 689
13. K. Iskander, A. Gaikwad, M. Paquet, D.n. Long, C. Brayton, R. Barrios, and A. Jaiswal Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis Cancer Res. 65 2005 2054 2058
14. J. Johnson, D. Johnson, A. Kraft, M. Calkins, R. Jakel, M. Vargas, and P. Chen The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration Ann. N. Y. Acad. Sci. 1147 2008 61 69
15. K. Kang, I. Cho, C. Lee, and S. Kim Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz J. Natl. Cancer Inst. 95 2003 53 66
16. M. Kapturczak, C. Wasserfall, T. Brusko, M. Campbell-Thompson, T. Ellis, M. Atkinson, and A. Agarwal Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse Am. J. Pathol. 165 2004 1045 1053
17. A. Karuri, Y. Huang, S. Bodreddigari, C. Sutter, B. Roebuck, T. Kensler, and T. Sutter 3H-1,2-dithiole-3-thione targets nuclear factor kappaB to block expression of inducible nitric-oxide synthase, prevents hypotension, and improves survival in endotoxemic rats J. Pharmacol. Exp. Ther. 317 2006 61 67
18. T. Kawakami, T. Takahashi, H. Shimizu, K. Nakahira, M. Takeuchi, H. Katayama, M. Yokoyama, K. Morita, R. Akagi, and S. Sassa Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachloride-induced hepatotoxicity Int. J. Mol. Med. 18 2006 537 546
19. B. Ke, X. Shen, S. Tsuchihashi, F. Gao, J. Araujo, R. Busuttil, T. Ritter, and J. Kupiec-Weglinski Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity Hum. Gene Ther. 18 2007 355 366
20. P. La, A. Fernando, Z. Wang, A. Salahudeen, G. Yang, Q. Lin, C. Wright, and P. Dennery Zinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition J. Biol. Chem. 284 2009 36302 36311
21. T. Lee, and L. Chau Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice Nat. Med. 8 2002 240 246
22. J. Lee, and J. Johnson An important role of Nrf2-ARE pathway in the cellular defense mechanism J. Biochem. Mol. Biol. 37 2004 139 143
23. C. Lee, S. Lee, S. Chen, F. Ho, and W. Lin Oregonin inhibits lipopolysaccharide-induced iNOS gene transcription and upregulates HO-1 expression in macrophages and microglia Br. J. Pharmacol. 146 2005 378 388
24. X. Li, M. Schwacha, I. Chaudry, and M. Choudhry Heme oxygenase-1 protects against neutrophil-mediated intestinal damage by down-regulation of neutrophil p47phox and p67phox activity and O2-production in a two-hit model of alcohol intoxication and burn injury J. Immunol. 180 2008 6933 6940
25. W. Lin, R. Wu, T. Wu, T. Khor, H. Wang, and A. Kong Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway Biochem. Pharmacol. 76 2008 967 973
26. Y. Liu, C. Hsieh, C. Wu, and B. Wung Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile Life Sci. 80 2007 1420 1430
27. Y. Luo, A. Eggler, D. Liu, G. Liu, A. Mesecar, and R. van Breemen Sites of alkylation of human Keap1 by natural chemoprevention agents J. Am. Soc. Mass Spectrom. 18 2007 2226 2232
28. D. Martin, A. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C. De Galarreta, and A. Cuadrado Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol J. Biol. Chem. 279 2004 8919 8929
29. P. McGeer, S. Itagaki, B. Boyes, and E. McGeer Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
30. K. Min, M. Yang, S. Kim, I. Jou, and E. Joe Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation J. Neurosci. 26 2006 1880 1887
31. M. Miyake, K. Fujimoto, S. Anai, S. Ohnishi, Y. Nakai, T. Inoue, Y. Matsumura, A. Tomioka, T. Ikeda, E. Okajima, N. Tanaka, and Y. Hirao Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells Anticancer Res. 30 2010 2145 2152
32. M. Mogi, T. Kondo, Y. Mizuno, and T. Nagatsu p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain Neurosci. Lett. 414 2007 94 97
33. R. Monteiro, C. Calhau, A. Silva, S. Pinheiro-Silva, S. Guerreiro, F. Gärtner, I. Azevedo, and R. Soares Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts J. Cell. Biochem. 104 2008 1699 1707
34. T. Murphy, M. De Long, and J. Coyle Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress J. Neurochem. 56 1991 990 995
35. P. Nioi, and J. Hayes Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors Mutat. Res. 555 2004 149 171
36. D. Noonan, R. Benelli, and A. Albini Angiogenesis and cancer prevention: a vision Recent Results Cancer Res. 174 2007 219 224
37. M. Okouchi, N. Okayama, J. Alexander, and T. Aw NRF2- dependent glutamate-l-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia-induced brain endothelial cell apoptosis Curr. Neurovasc. Res. 3 2006 249 261
38. Y. Omata, Y. Saito, K. Fujita, Y. Ogawa, K. Nishio, Y. Yoshida, and E. Niki Induction of adaptive response and enhancement of PC12 cell tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation Free Radic. Biol. Med. 45 2008 1437 1445
39. L. Otterbein, F. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, R. Davis, R. Flavell, and A. Choi Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat. Med. 6 2000 422 428
40. M. Reale, C. Iarlori, A. Thomas, D. Gambi, B. Perfetti, M. Di Nicola, and M. Onofrj Peripheral cytokines profile in Parkinson's disease Brain Behav. Immun. 23 2009 55 63
41. K. Roebuck Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review) Int. J. Mol. Med. 4 1999 223 230
42. S. Shibahara Regulation of heme oxygenase gene expression Semin. Hematol. 25 1988 370 376
43. S. Sugama Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders Med. Hypotheses 73 2009 1031 1034
44. P. Syapin Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders Br. J. Pharmacol. 155 2008 623 640
45. R. Thimmulappa, H. Lee, T. Rangasamy, S. Reddy, M. Yamamoto, T. Kensler, and S. Biswal Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis J. Clin. Invest. 116 2006 984 995
46. G. Turchini, G. Quinn, P. Jones, G. Palmeri, and G. Gooley Traceability and discrimination among differently farmed fish: a case study on Australian Murray cod J. Agric. Food Chem. 57 2009 274 281
47. B. Vanhoecke, F. Delporte, E. Van Braeckel, A. Heyerick, H. Depypere, M. Nuytinck, D. De Keukeleire, and M. Bracke A safety study of oral tangeretin and xanthohumol administration to laboratory mice In Vivo 19 2005 103 107
48. H. Wilms, L. Zecca, P. Rosenstiel, J. Sievers, G. Deuschl, and R. Lucius Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Curr. Pharm. Des. 13 2007 1925 1928
49. C. Wu, C. Hsieh, P. Lai, J. Lin, Y. Liu, and B. Wung Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein Toxicol. Appl. Pharmacol. 214 2006 244 252
50. M. Yates, Q. Tran, P. Dolan, W. Osburn, S. Shin, C. McCulloch, J. Silkworth, K. Taguchi, M. Yamamoto, C. Williams, K. Liby, M. Sporn, T. Sutter, and T. Kensler Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice Carcinogenesis 30 2009 1024 1031
51. C. Yeh, T. Chen, Y. Wang, Y. Lin, and P. Lin HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion J. Surg. Res. 155 2009 147 156
52. K. Youdim, M. Qaiser, D. Begley, C. Rice-Evans, and N. Abbott Flavonoid permeability across an in situ model of the blood-brain barrier Free Radic. Biol. Med. 36 2004 592 604
53. P. Zanoli, and M. Zavatti Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol. 116 2008 383 396
54. M. Zhou, L. Gu, N. Zhu, W. Woods, and H. Findley Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53 Oncogene 22 2003 8137 8144